蛋白激酶A研究新进展(3)

　　参考文献

　　1Stratakis CA.Clinical and molecular features of the Carney comples:diagnostic criteria and recommendations for patient evaluation[J]J Clin Endocrinol Metab,2001，86:4041

　　2Cho YS.Protein kinase and human diease[J]Trend Endo Meta,2002,13(2):50

　　3EvenRam SC,Maoz M,Pokroy E,et alTumor cell invasion is promoted by activation of protease activated receptorlin cooperation with the alpha(V) beta(5) integrin[J]J Biol Chem,2001,276:472

　　4C　Rudroff S,Striegler M.Scheele,Throbin enhances adhension in pancreatic cancer in vitro through the activation of the thrombin receptor PARⅠ[J]Eur J Surg Oncol,2001，27:472

　　5Kaufann R.The serine proteinase tfrombin promotes migration of human renal carcinoma cells by a PKAdependent mechanism[J]Clin Cancer Res,2002,180:183

　　6Nesterova M,Noguchi K,G Park Y,et alCompensatory stabilization of RⅡβ protein,cell cycle deregulation,and growth arrest in colon and prostate carcinoma cells by antisensedirected dowmregulation of protein kinase A R1α protein[J]Clin Cancer Res,2000,6:3434

　　7Rosenberg D,Groussin L,Jullian E,et alRole of the PKAregulated transcription factor CREB in development and tumorigenesis of endocrine tissues[J]Ann N Y Acad Sci,2002,968:65

　　8Cho YS,Kim MK,Cheadle C,et al.Antisense DNAs as multisite genomic modulators identigied by DNA microarray[J]Proc Mat1 Acad Sci USA,2001,98:9819

　　9Tortora G,Ciardiello FProtein Kinase A as target for novel integrated strategies of cancer therapy[J]Ann N Y Acad Sci,2002,968:139

　　10Jansen B,Wacheck V,HeereRess E,et alChemosensitisation of malignant melanoma by BCL2 antisense therapy[J]Lancet,2000,356:1728

　　11Waters JS,Webb A,Cunningham D,et al.Phase Ⅰclinical and pharmacokinetic study of bc12 antisense oligonucleotide therapy in patients with non Hodgkin’s lymphoma[J]J Clin Oncol,2000,18:1812

　　12Mendelsohn J,Baselga J.The EGF receptor family as targets for cancer therapy[J]Oncogene,2000,19:6550

　　13Woodburn JThe epidermal growth factor receptor and its inhibition in cancer therapy [J]Pharmacol Ther,1999,82:241

　　14Ciardiello F,Tortora GAA novel approach in the treatment of cancer:targeting the epidermal growth facor receptor[J]Clin Cancer Res,2001,7:2958

　　15Tortora GA,Caputo R,Damisno V,et alCombined targeted inhibition of bc12,bclXL,epidermal growth factor receptor and protein kinase A type Ⅰ cause protent antitumor,apoptotic and antiangiogenic activity[J]Clin Cancer Res,2003,9:866

　　16Cho YS,ChoChung YS.Antisense protein kinase A R1α acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells:molecular basis for cobinatorial therapy[J]Clin Cancer Res,2003,9:1171

　　17Tortor G,Caputo R,Damiano V,et al.Combination of a selective cuclooxygenase2 inbibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect[J]Clin Cancer Res,2003,9(4):1566